发明申请
US20050153358A1 High-throughput screening method for determining the enantioselectivity of catalysts, biocatalysts, and agents
审中-公开
用于确定催化剂,生物催化剂和试剂的对映体选择性的高通量筛选方法
- 专利标题: High-throughput screening method for determining the enantioselectivity of catalysts, biocatalysts, and agents
- 专利标题(中): 用于确定催化剂,生物催化剂和试剂的对映体选择性的高通量筛选方法
-
申请号: US10506144申请日: 2003-02-22
-
公开(公告)号: US20050153358A1公开(公告)日: 2005-07-14
- 发明人: Manfred Reetz , Patrick Tielmann , Andreas Eipper , Richard Mynott
- 申请人: Manfred Reetz , Patrick Tielmann , Andreas Eipper , Richard Mynott
- 申请人地址: DE Mulheim an der Ruhr
- 专利权人: Studiengesellschaft Kohle mbH
- 当前专利权人: Studiengesellschaft Kohle mbH
- 当前专利权人地址: DE Mulheim an der Ruhr
- 优先权: DE10209177.3 20020301
- 国际申请: PCT/EP03/01825 WO 20030222
- 主分类号: G01N24/08
- IPC分类号: G01N24/08 ; C07C27/02 ; C07C31/12 ; C07C33/20 ; C07C69/013 ; C07C69/145 ; G01N37/00 ; G01R33/30 ; G01R33/46 ; G01N33/53 ; G01N33/543
摘要:
The invention relates to a high-throughput screening method based on NMR spectroscopy for determining the enantioselectivity of reactions which show an asymmetric course. The reactions can be caused by chiral catalysts, agents, or biocatalysts such that said products can be evaluated regarding the enantioselectivity thereof. In one embodiment, isotope-marked pseudo-enantiomers or pseudo-prochiral substrates are used such that the enantioselectivity can be quantified by integrating the NMR signals of the respective substrates and/or products. The use of an automated setup of devices, including microtiter plates, robots, and high-throughput NMR devices, is decisive for the high-throughput process. In a second embodiment of the invention, the automated setup of devices is used to detect in a quantitative manner the products and/or educts that have been derivatized with enantiomer-pure agents in the form of diastereomers. At least 1000 ee determinations can be done per day with accuracy of at least ±5 percent in both embodiments.
信息查询